129 related articles for article (PubMed ID: 21842119)
1. Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells.
Yoshikawa Y; Sato A; Tsujimura T; Morinaga T; Fukuoka K; Yamada S; Murakami A; Kondo N; Matsumoto S; Okumura Y; Tanaka F; Hasegawa S; Hashimoto-Tamaoki T; Nakano T
Int J Oncol; 2011 Dec; 39(6):1365-74. PubMed ID: 21842119
[TBL] [Abstract][Full Text] [Related]
2. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
[TBL] [Abstract][Full Text] [Related]
4. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].
Liu XQ; Sun M; Chen HK; Li JX; Pan ZG; Long QX; Wang XZ; Zeng YX
Ai Zheng; 2003 Jan; 22(1):16-20. PubMed ID: 12561429
[TBL] [Abstract][Full Text] [Related]
5. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.
Taniguchi T; Karnan S; Fukui T; Yokoyama T; Tagawa H; Yokoi K; Ueda Y; Mitsudomi T; Horio Y; Hida T; Yatabe Y; Seto M; Sekido Y
Cancer Sci; 2007 Mar; 98(3):438-46. PubMed ID: 17270034
[TBL] [Abstract][Full Text] [Related]
6. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.
Nair PN; McArdle L; Cornell J; Cohn SL; Stallings RL
Cancer Genet Cytogenet; 2007 Apr; 174(2):100-10. PubMed ID: 17452250
[TBL] [Abstract][Full Text] [Related]
7. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion.
Usami N; Sekido Y; Maeda O; Yamamoto K; Minna JD; Hasegawa Y; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
Oncogene; 2003 Sep; 22(39):7923-30. PubMed ID: 12970740
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
10. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer.
Xiang RH; Hensel CH; Garcia DK; Carlson HC; Kok K; Daly MC; Kerbacher K; van den Berg A; Veldhuis P; Buys CH; Naylor SL
Genomics; 1996 Feb; 32(1):39-48. PubMed ID: 8786119
[TBL] [Abstract][Full Text] [Related]
11. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma.
Balsara BR; Bell DW; Sonoda G; De Rienzo A; du Manoir S; Jhanwar SC; Testa JR
Cancer Res; 1999 Jan; 59(2):450-4. PubMed ID: 9927061
[TBL] [Abstract][Full Text] [Related]
13. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.
Futamura M; Kamino H; Miyamoto Y; Kitamura N; Nakamura Y; Ohnishi S; Masuda Y; Arakawa H
Cancer Res; 2007 Feb; 67(4):1451-60. PubMed ID: 17308083
[TBL] [Abstract][Full Text] [Related]
14. [Semaphorins and cancers : an up 'dating'].
Nasarre P; Constantin B; Drabkin HA; Roche J
Med Sci (Paris); 2005; 21(6-7):641-7. PubMed ID: 15985208
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
[TBL] [Abstract][Full Text] [Related]
16. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.
Shigemitsu K; Sekido Y; Usami N; Mori S; Sato M; Horio Y; Hasegawa Y; Bader SA; Gazdar AF; Minna JD; Hida T; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
Oncogene; 2001 Jul; 20(31):4249-57. PubMed ID: 11464291
[TBL] [Abstract][Full Text] [Related]
17. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line.
Tse C; Xiang RH; Bracht T; Naylor SL
Cancer Res; 2002 Jan; 62(2):542-6. PubMed ID: 11809707
[TBL] [Abstract][Full Text] [Related]
18. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma.
Shivapurkar N; Virmani AK; Wistuba II; Milchgrub S; Mackay B; Minna JD; Gazdar AF
Clin Cancer Res; 1999 Jan; 5(1):17-23. PubMed ID: 9918198
[TBL] [Abstract][Full Text] [Related]
19. LATS2 is a tumor suppressor gene of malignant mesothelioma.
Murakami H; Mizuno T; Taniguchi T; Fujii M; Ishiguro F; Fukui T; Akatsuka S; Horio Y; Hida T; Kondo Y; Toyokuni S; Osada H; Sekido Y
Cancer Res; 2011 Feb; 71(3):873-83. PubMed ID: 21245096
[TBL] [Abstract][Full Text] [Related]
20. Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.
Nguyen H; Ivanova VS; Kavandi L; Rodriguez GC; Maxwell GL; Syed V
Mol Cancer Res; 2011 Nov; 9(11):1479-92. PubMed ID: 21933904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
